Residency · Residency · Child Adolescent Psychiatry

Anorexia Nervosa in Adolescents: Medical Stabilization and Refeeding

Overview

Anorexia nervosa (AN) has the highest mortality rate of any psychiatric disorder, with death occurring primarily from cardiac complications and suicide. Peak onset is during adolescence, between ages 14 and 18, though the age of onset is trending younger. Lifetime prevalence is approximately 0.5-2% in adolescent females, with increasing recognition that males account for approximately 10-25% of cases. Medical complications can be life-threatening and require close coordination between psychiatry, pediatrics or adolescent medicine, and nutrition. Refeeding syndrome is a potentially fatal complication of nutritional rehabilitation that must be anticipated and monitored. Family-Based Treatment (the Maudsley approach) is the first-line evidence-based psychotherapy for adolescent AN.

Medical Complications

Cardiovascular

The most common cardiac finding in AN is bradycardia, with a resting heart rate below 50 bpm, reflecting physiological adaptation to starvation. Hypotension with orthostatic changes (a drop in systolic blood pressure greater than 20 mmHg or diastolic greater than 10 mmHg upon standing) is common. QTc prolongation carries a risk of arrhythmia and sudden cardiac death, particularly when exacerbated by electrolyte abnormalities such as hypokalemia and hypomagnesemia. Mitral valve prolapse may develop due to decreased left ventricular mass. Pericardial effusion is rare but has been reported in severe malnutrition. Heart failure during refeeding can occur if nutritional rehabilitation proceeds too rapidly.

Electrolyte and Metabolic

Hypokalemia is especially dangerous with purging behaviors (vomiting or laxative abuse) due to the risk of cardiac arrhythmia. Hyponatremia may result from excessive water intake or impaired renal concentration. Hypophosphatemia is the hallmark electrolyte abnormality of refeeding syndrome. Hypomagnesemia carries risk of cardiac arrhythmia and seizures. Hypoglycemia from depleted glycogen stores can cause seizures and altered consciousness. Metabolic alkalosis develops from purging with loss of gastric acid, while metabolic acidosis develops from laxative abuse with loss of bicarbonate.

Endocrine

Hypothalamic amenorrhea results from suppressed GnRH, though loss of menstruation is no longer required for diagnosis under DSM-5. Low estrogen and testosterone contribute to bone density loss. Elevated cortisol reflects the stress response to starvation. Low T3 syndrome (sick euthyroid) is an adaptive response that does not require thyroid replacement. Growth hormone resistance produces elevated GH but low IGF-1. In prepubertal and early pubertal patients, delayed puberty may occur.

Bone Health

Osteopenia and osteoporosis occur in up to 85% of adolescents with AN. This is particularly consequential because adolescence is the critical window for bone mineral density accrual, and AN during this period can cause permanent bone density deficits. DEXA scanning is recommended if amenorrhea or low weight has persisted for more than 6 months. Weight restoration is the most effective treatment for improving bone density. Importantly, estrogen supplementation has not been shown to improve bone density in AN, unlike its role in postmenopausal osteoporosis.

Gastrointestinal

Delayed gastric emptying produces early satiety, bloating, and nausea, which complicate refeeding efforts. Constipation results from dehydration, decreased gut motility, and low fiber intake. Superior mesenteric artery (SMA) syndrome involves compression of the duodenum between the SMA and aorta due to loss of mesenteric fat. Elevated transaminases from starvation-related hepatic injury are usually reversible with refeeding.

Hematological

Leukopenia, anemia, and thrombocytopenia result from starvation-induced bone marrow suppression. These abnormalities are usually reversible with nutritional rehabilitation. Clinicians should not attribute leukopenia to infection without first assessing nutritional status.

Neurological

Cerebral atrophy with gray and white matter loss occurs but is partially reversible with weight restoration. Peripheral neuropathy may develop. Cognitive impairment, including poor concentration and decreased processing speed, is common.

Criteria for Inpatient Medical Stabilization

Inpatient medical admission is indicated when the heart rate falls below 50 bpm (or below 40 bpm in some protocols), systolic blood pressure is below 90 mmHg or orthostatic changes are present, temperature is below 96 degrees F (35.6 degrees C), electrolyte abnormalities are present (especially potassium below 3.0 or low phosphate), blood glucose is below 60 mg/dL, weight is below 75% of expected body weight or weight loss has been rapid, syncope or near-syncope has occurred, outpatient treatment has failed, or there is acute psychiatric risk including suicidality or psychosis.

Refeeding Syndrome

Pathophysiology

During starvation, the body shifts from carbohydrate to fat metabolism, and intracellular stores of phosphate, potassium, and magnesium become depleted even though serum levels may appear normal. Upon reintroduction of carbohydrate, insulin secretion increases, driving phosphate, potassium, and magnesium into cells. This produces precipitous drops in serum electrolytes, particularly phosphorus. Fluid retention occurs due to insulin-mediated sodium and water reabsorption. The combination can cause cardiac arrhythmia, heart failure, respiratory failure, seizures, delirium, and death.

Risk Factors for Refeeding Syndrome

Risk factors include very low BMI (below 70% of expected body weight), prolonged fasting or very low caloric intake for more than 10 days, a history of purging behaviors, baseline electrolyte abnormalities, and a rapid rate of caloric increase during refeeding.

Prevention and Monitoring

The traditional approach to prevention is to start low and advance slowly, beginning at 1200-1500 kcal/day and increasing by 200-300 kcal every 1-2 days. More recent evidence, including the MARSIPAN guidelines and studies by O'Connor and Goldin, suggests that higher initial caloric prescriptions (1500-2000+ kcal/day) may be safe with careful monitoring, particularly in medical inpatient settings. Prophylactic phosphate supplementation is increasingly recommended for high-risk patients. Electrolyte monitoring should include phosphorus, potassium, magnesium, and glucose at least daily during the first 5-7 days of refeeding, with twice-daily monitoring in high-risk patients. Fluid monitoring should track fluid balance, daily weights, and intake and output, with IV fluids restricted during refeeding. Cardiac monitoring with continuous telemetry is indicated for high-risk patients during the initial refeeding period. Thiamine supplementation should be administered before and during refeeding to prevent Wernicke encephalopathy.

Management of Refeeding Hypophosphatemia

If phosphorus drops below 3.0 mg/dL, oral phosphate supplementation should be initiated and caloric advancement slowed. If phosphorus drops below 2.0 mg/dL, IV phosphate replacement is required, caloric increase should be halted, and continuous cardiac monitoring initiated. Magnesium and potassium should be corrected simultaneously, as they are often co-depleted.

Nutritional Rehabilitation

Inpatient Protocols

In inpatient settings, the target weight gain is 1-2 kg per week. Meal plans typically advance to 3 meals plus 3 snacks. Meals should be supervised with post-meal observation for 30-60 minutes to prevent purging. Nasogastric tube feeding may be used if the patient refuses oral intake or cannot meet caloric goals; this is a medical intervention and should never be framed as punishment. A dietitian should be involved for meal planning, and the patient should not be given excessive control over food choices initially.

Outpatient Nutritional Rehabilitation

In outpatient settings, the target weight gain is 0.5-1 kg per week. Regular weigh-ins are important, and blind weighing may reduce anxiety. Family-Based Treatment empowers parents to manage meals. The target weight range is determined by the point at which menstruation resumes, growth curves normalize, and vital signs stabilize, which is often at or above 95% of expected body weight.

Psychiatric Management

SSRIs have limited evidence in the acute underweight phase because medications are less effective in the malnourished state. Fluoxetine is the only antidepressant with evidence for relapse prevention in weight-restored adults. Atypical antipsychotics, particularly olanzapine, have been studied for promoting weight gain and reducing anxiety around eating, with some evidence supporting their use, but concerns about metabolic side effects mean they are not a standard treatment. The most important clinical principle is that no medication has strong evidence for treating core AN symptoms during the acute phase — nutritional rehabilitation is the primary treatment. Comorbid conditions such as depression, anxiety, and OCD should be treated once nutritional status is stabilized. Safety assessment for suicidality should be conducted routinely, as suicide is a significant cause of death in AN.

<image>A table summarizing the medical complications of anorexia nervosa organized by organ system. Systems include: cardiovascular (bradycardia, hypotension, QTc prolongation), electrolyte (hypokalemia, hypophosphatemia, hypomagnesemia), endocrine (amenorrhea, low estrogen, sick euthyroid, elevated cortisol), bone (osteopenia/osteoporosis), GI (delayed gastric emptying, SMA syndrome, elevated LFTs), hematologic (pancytopenia), and neurological (cerebral atrophy, cognitive impairment). For each complication, note the mechanism and clinical significance.</image>

<image>A flowchart depicting the pathophysiology and management of refeeding syndrome. Start with prolonged starvation (depleted intracellular phosphate, potassium, magnesium stores). Then show reintroduction of carbohydrate leading to insulin surge, which drives electrolytes intracellularly, causing precipitous drops in serum phosphorus, potassium, and magnesium. Show the consequences: cardiac arrhythmia, heart failure, respiratory failure, seizures, death. Show the prevention strategy: start low advance slowly, prophylactic phosphate, daily electrolyte monitoring, thiamine supplementation, cardiac monitoring.</image>

<image>An inpatient admission criteria checklist for adolescents with anorexia nervosa. Show vital sign thresholds (HR <50, SBP <90, temp <96F), laboratory abnormalities (K <3.0, glucose <60, low phosphorus), weight criteria (<75% expected body weight, rapid weight loss), and psychiatric criteria (suicidality, psychosis, failure of outpatient treatment). Format as a clinical decision aid with red flags highlighted.</image>

Clinical Pearls

AN has the highest mortality of any psychiatric disorder, and medical complications must be taken seriously and monitored systematically. Refeeding syndrome is preventable with appropriate monitoring and gradual caloric advancement, and phosphorus is the key electrolyte to watch. Bradycardia in AN reflects physiological adaptation to starvation, not athletic conditioning, and should never be dismissed. Leukopenia in AN is caused by bone marrow suppression from malnutrition, not infection, and resolves with refeeding. Serum electrolytes may appear normal in severe AN because intracellular stores are depleted; the depletion becomes apparent only upon refeeding. No medication is effective for core AN symptoms in the acute underweight phase, and nutritional rehabilitation is the treatment. Osteopenia in adolescent AN can cause permanent bone density deficits because adolescence is the critical window for peak bone mass accrual. SMA syndrome should be suspected in severely underweight patients who present with persistent vomiting and epigastric pain.

References

• Golden, N.H. et al. (2015). Position paper of the Society for Adolescent Health and Medicine: medical management of restrictive eating disorders in adolescents. Journal of Adolescent Health, 56(1), 121-125.
• Garber, A.K. et al. (2016). A systematic review of approaches to refeeding in patients with anorexia nervosa. International Journal of Eating Disorders, 49(3), 293-310.
• Mehler, P.S. & Brown, C. (2015). Anorexia nervosa: medical complications. Journal of Eating Disorders, 3, 11.
• MARSIPAN (Management of Really Sick Patients with Anorexia Nervosa) guidelines. Royal College of Psychiatrists, 2014.
• Misra, M. et al. (2011). Bone metabolism in adolescent boys with anorexia nervosa. Journal of Clinical Endocrinology & Metabolism, 93(8), 3029-3036.
• American Psychiatric Association. (2023). Practice guidelines for the treatment of eating disorders.

Read this lecture as Markdown